Florence Welcomes Steve Chamberlain to Advisory Board

Atlanta, GA, April 3, 2019 (Newswire.com) – Florence, the company that advances clinical trials with software, welcomes healthcare IT industry veteran, Steve Chamberlain to its Advisory Network. Chamberlain, who also made an undisclosed investment in Florence, brings experience driving growth at disruptive companies including WebMD and Mana Health. “A business thrives based on the drive of the people behind it.” Says Chamberlain, “The team at Florence, including its Advisors, are making an impact on Clinical Research and therefore the pace of cures. I’m delighted to join them as their growth accelerates.”

“This year will be challenging and productive for our Advisory Network,” notes Ryan Jones, Florence CEO. “Precision medicine is changing the array of therapies under study. As a result, research technologies, like Florence eBinders, eHub and eTMF, must help research teams manage through change. Our Advisory Network will help us build products aligned with our customers’ needs and allow us to grow to help thousands of more research teams in 2019.”​

About Florence:Florence advances clinical trials through software for managing document and data flow between research sites and sponsors. Florence eBinders is trusted by 4,000+ research teams to manage eRegulatory/eSource for over 1,000 studies; Florence eTMF is the most flexible eTMF on the market with a wide range of innovative features; and Florence eHub is revolutionizing site-sponsor connectivity for site oversight, monitoring, startup, and quality control.